Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2007
11/01/2007CA2646671A1 Methods and compositions for localized secretion of anti-ctla-4 antibodies
11/01/2007CA2637222A1 Expression control elements from the lemnaceae family
10/2007
10/31/2007EP1850131A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
10/31/2007EP1850130A1 Gene markers and utilzation of the same
10/31/2007EP1849874A1 L-cysteine producing microorganism and a method for producing L-cysteine
10/31/2007EP1849873A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
10/31/2007EP1849872A1 Adeno-associated virus vectors and uses thereof
10/31/2007EP1849871A1 Tomato plants having higher levels of resistance to Botrytis
10/31/2007EP1849870A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (IDDM)
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849868A2 Plant defensins
10/31/2007EP1849867A1 Preparation of antibody using mrl/lpr mouse
10/31/2007EP1849866A2 Human orphan G protein-coupled receptors
10/31/2007EP1849865A1 RNAi MEDICINE HAVING NO ADVERSE EFFECTS
10/31/2007EP1849864A1 Method for determining phospholipidosis
10/31/2007EP1849863A1 Non-human chimeric animal and use thereof
10/31/2007EP1849859A1 Novel polyester plastic-degrading microorganism, polyester plastic-degrading enzyme and polynucleotide encoding the enzyme
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849801A1 Tyrosine-based motif and clostridial neurotoxins
10/31/2007EP1849800A2 Moraxella catarrhalis proteins
10/31/2007EP1849799A1 Modified virus capsid protein and the use thereof
10/31/2007EP1849480A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
10/31/2007EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
10/31/2007EP1849474A1 Antimicrobial peptide and use thereof
10/31/2007EP1848827A2 Methods and compositions for tagging and identifying polynucleotides
10/31/2007EP1848824A1 Selected compaction agents and methods and compositions for biotechnical separations
10/31/2007EP1848812A2 Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
10/31/2007EP1848808A1 Plant cyclopropane fatty acid synthase genes and uses thereof
10/31/2007EP1848807A1 Transcription regulating nucleotide sequence from solanaceae triose-phosphate translocator genes and their use in plant expression cassettes
10/31/2007EP1848806A1 Anti-t cell and autoantigen treatment of autoimmune disease
10/31/2007EP1848805A2 Pharmaceutical agents for preventing metastasis of cancer
10/31/2007EP1848804A2 Anti-muci alpha beta antibodies
10/31/2007EP1848803A2 Rnai-mediated inhibition of ocular hypertension targets
10/31/2007EP1848802A1 Compounds
10/31/2007EP1848801A1 Composition and methods for protein design
10/31/2007EP1848800A2 Novel gene vcs 02
10/31/2007EP1848743A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
10/31/2007EP1848741A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
10/31/2007EP1848737A2 Homogeneous preparations of il-31
10/31/2007EP1848684A1 Ester-linked gemini surfactant compounds for use in gene therapy
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1848456A2 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
10/31/2007EP1848410A1 Polymer particle delivery compositions and methods of use
10/31/2007EP1848265A2 Plant defense signal peptides
10/31/2007EP1766044A4 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
10/31/2007EP1730287A4 Inducible promoters
10/31/2007EP1706506A4 A sensitive and specific test to detect sars coronavirus
10/31/2007EP1697534A4 Nucleic acid molecules containing recombination sites and methods of using the same
10/31/2007EP1692179A4 An antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same
10/31/2007EP1509606B1 Allergen from mugwort pollen
10/31/2007EP1438435B1 Methods for blocking nonspecific hybridisations of nucleic acid sequences
10/31/2007EP1425417B1 Interaction detection on several probe arrays
10/31/2007EP1399567B1 Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase
10/31/2007EP1390522B1 Acetate-free purification of plasmid dna on hydroxyapatite
10/31/2007EP1372691B1 Mucin peptide with immunoenhancing properties
10/31/2007EP1368460B1 Real-time sequence determination
10/31/2007EP1362915B1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same
10/31/2007EP1259626B1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
10/31/2007EP1255838B1 Dehiscence gene and methods for regulating dehiscence
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1183346B1 Method for generating split, non-transferable genes that are able to express an active protein product
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1165791B1 Human cytokine as ligand of the zalpha receptor and uses thereof
10/31/2007EP1163912B1 Gene therapeutics
10/31/2007EP1131422B1 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
10/31/2007EP1105511B1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors
10/31/2007EP1104489B1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids
10/31/2007EP1078079B1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
10/31/2007EP1078004B1 Tetravalent antibody constructs
10/31/2007EP1068352B1 Nucleic acid detection method
10/31/2007EP1054986B1 Isolated and purified nucleic acids comprising a gene specifically expressed in hop glands
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007EP0942965B1 Novel gene coding for an amino acid deacetylase with specificity for n-acetyl-l-phosphinothricin, their isolation and their use
10/31/2007EP0898618B1 Method of providing novel dna sequences
10/31/2007EP0871645B1 Modulators of the function of fas/apo1 receptors
10/31/2007EP0851030B9 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO
10/31/2007DE19515310B4 Isoelastische Hüftendoprothese Isoelastic hip replacement
10/31/2007DE10014639B4 cDNSen mit einer Kodierung von Enzymen zur Fructan-Synthese mit einer Niedertemperatur-Expression sowie Verfahren zu deren Isolierung cDNSen with a coding for enzymes of fructan synthesis with a low-temperature expression as well as methods for their isolation
10/31/2007CN101065668A Double hybrid system based on gene silencing by transcriptional interference
10/31/2007CN101065501A Method for determining genotoxicity
10/31/2007CN101065492A Viral vectors
10/31/2007CN101065491A Collagen producing plants and methods of generating and using same
10/31/2007CN101065490A Promoter molecules isolated from brassica napus for use in plants
10/31/2007CN101065489A Construct of swine vesicular disease virus like particle using genetic engineering and the method for manufacturing thereof
10/31/2007CN101065488A Method of delivery of nucleic acids to peripheral neurons
10/31/2007CN101065487A Retinal dystrophin transgene and methods of use thereof
10/31/2007CN101065486A Multifunctional and multivalent angiogenesis inhibitors
10/31/2007CN101065484A L-amino acid-producing bacterium and a method for producing l-amino acid
10/31/2007CN101065483A Method of identifying nucleotide polymorphisms
10/31/2007CN101065482A Novel shuttle vector
10/31/2007CN101065481A Nicotiana nucleic acid molecules and uses thereof
10/31/2007CN101065477A Process for producing substances
10/31/2007CN101065400A Genetically engineered cells for therapeutic applications
10/31/2007CN101065397A A bacterial ATP synthase binding domain
10/31/2007CN101065365A Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
10/31/2007CN101065145A A chimeric G protein based rabies vaccine
10/31/2007CN101065096A Duffy antigen receptor for chemokines and use thereof
10/31/2007CN101065013A Certain plants with no saturate or reduced saturate levels of fatty acids in seeds, and oil derived from the seeds
10/31/2007CN101063173A Pig breeding and respiration syndrome virus ultrastrong variation strain RT-PCR reagent case
1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 4023